facebook-pixel

SEC fines Utah company over misleading COVID-19 test claims, not disclosing payments to executives’ relatives

Co-Diagnostics saw its stock price soar after it described its coronavirus tests — approved only for research — as accurate and available for use.

(AP File Photo | Rick Bowmer) A Co-Diagnostics lab technician worked with sample tests as the company produced COVID-19 testing kits March 27, 2020, in Salt Lake City. The Securities and Exchange Commission announced Wednesday it had issued a cease and desist order against Co-Diagnostics in connection with violations of the Securities and Exchange acts and assessed the company a $250,000 civil penalty.